Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma

Stopped Unable to recruit the projected patient number. All analyses are descriptive, only.

Conditions

• Anaplastic Astrocytoma
• Glioblastoma

Interventions

• DRUG: trabedersen
• DRUG: temozolomide
• DEVICE: Drug delivery system for administration of AP 12009
• PROCEDURE: Placement of Drug Delivery System
• DRUG: carmustine
• DRUG: lomustine

Sponsor

Isarna Therapeutics GmbH